Consumer staples ETFs have drawn renewed attention as investors weigh defensive positioning against evolving inflation, interest-rate, and consumer-spending trends. While FSTA and FXG both operate within the consumer staples universe, they represent fundamentally different investment approaches rather than direct competitors. FSTA offers broad, capitalization-weighted exposure to the sector's largest and most established companies, while FXG applies a factor-screening methodology designed to tilt toward stocks exhibiting value and growth characteristics. This ETF comparison clarifies how structural differences in sector exposure, cost structure, and fund performance shape relative positioning for investors seeking either a core staples allocation or a more tactical, factor-driven expression of the theme. I also checked this using Tickeron’s AI Screener to see how the two funds compare on key metrics.
FSTA is a passively managed fund that seeks to track the performance of the MSCI USA IMI Consumer Staples 25/50 Index, a market-capitalization-weighted benchmark covering the U.S. consumer staples segment. The fund holds roughly 100 stocks, spanning large, mid, and small capitalization names, with a pronounced tilt toward mega-caps. Top holdings include Walmart, Costco Wholesale, Procter & Gamble, Coca-Cola, Philip Morris International, PepsiCo, Altria Group, Mondelez International, Colgate-Palmolive, and Monster Beverage. Its low 0.08% expense ratio and substantial liquidity make it an efficient core vehicle for broad sector exposure. From what I see, the fund’s construction provides steady access to the sector’s largest players.
FXG tracks the StrataQuant Consumer Staples Index, which uses First Trust's AlphaDEX screening methodology to select and weight stocks from the Russell 1000 Index. The fund applies growth factors (such as price appreciation and sales growth) and value factors (such as book value, cash flow, and return on assets) to rank constituents, then assigns higher weights to the top-ranked quintiles. This produces a modified equal-weight portfolio of roughly 41 holdings that is reconstituted and rebalanced quarterly. Top holdings include Cardinal Health, Freshpet, Post Holdings, Pilgrim's Pride, McCormick, Ingredion, Smithfield Foods, Seaboard, Constellation Brands, and McKesson. Its higher 0.63% expense ratio reflects the more active, factor-driven construction process. One thing that stands out is how the quarterly rebalancing can shift exposure in ways a simple index does not.
The consumer staples sector has been shaped by persistent concerns over pricing power, input costs, and shifting consumer behavior. Household names with strong brand loyalty and defensive revenue streams have generally held up well, while commodity-sensitive food producers and distributors have faced more volatile margins. Meanwhile, staples' traditional role as a defensive, income-oriented allocation has been tested by higher yields, which reduce the relative appeal of dividend-paying equities. Within this environment, mega-cap retailers and branded packaged-goods companies have shown steadier demand, whereas mid-cap food and protein producers in FXG's portfolio remain more exposed to agricultural input cycles and consumer trade-down dynamics. These macro forces influence both funds but affect them differently given their divergent weighting and sector composition.
In recent market cycles, FSTA has demonstrated more consistent relative strength, supported by the resilient earnings of its mega-cap holdings and the compounding effect of its minimal fee. FXG, by contrast, has lagged over recent weeks and months as its tilt toward mid-cap food, beverage, and distribution names contended with softer demand and margin pressure. FXG's portfolio also drifts beyond pure staples exposure, carrying meaningful allocations to healthcare and industrial names that can alter its behavior relative to the broader staples complex. From a volatility standpoint, both funds are historically less volatile than the broader equity market, but FSTA's diversified mega-cap base has provided a smoother relative risk profile, while FXG's concentrated, factor-driven selection has introduced greater idiosyncratic risk. I’m watching this closely as the relative performance gap could persist if mega-caps continue to lead.
When comparing funds like these, I often rely on Tickeron’s AI Screener to quickly filter for sector exposure, expense ratios, and historical patterns. The platform lets me scan ETFs alongside individual holdings using customizable criteria, which helps surface how FSTA’s broad diversification stacks up against FXG’s more concentrated approach without manually pulling dozens of data points. It has become a regular part of my workflow for refining ideas before making allocation decisions.
Based on observable structural factors, Tickeron's AI would currently favor FSTA over FXG. FSTA's materially lower expense ratio, broader diversification across roughly 100 holdings, and concentration in high-quality, mega-cap franchises offer a stronger cost-efficiency and risk-adjusted foundation. Its more consistent trend profile in recent market cycles contrasts with FXG's factor-driven tilt toward smaller, more cyclical food and distribution names that have shown weaker momentum. While FXG may appeal to investors seeking a tactical, factor-based approach, FSTA's durability, liquidity, and pure-play sector alignment make it the more probable preferred choice in the current environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
FXG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 38 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 73 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.
Following a +1.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 176 of 272 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows